We have recently demonstrated that secretin-stimulated transabdominal ultrasonography (s-US) can detect reduced pancreatic secretion in various pancreatic diseases, and best accuracy for exocrine pancreatic failure was achieved for the method in CF patients [17]. This evidence concerns the gene SCT and pancreas disorder.